Your browser doesn't support javascript.
loading
Protocol for the Stimulating ß3-Adrenergic Receptors for Peripheral Artery Disease (STAR-PAD) trial: a double-blinded, randomised, placebo-controlled study evaluating the effects of mirabegron on functional performance in patients with peripheral arterial disease.
Bubb, Kristen J; Harmer, Jason A; Finemore, Meghan; Aitken, Sarah Joy; Ali, Zara S; Billot, Laurent; Chow, Clara; Golledge, Jonathan; Mister, Rebecca; Gray, Michael P; Grieve, Stuart M; Hamburg, Naomi; Keech, Anthony C; Patel, Sanjay; Puttaswamy, Vikram; Figtree, Gemma A.
Affiliation
  • Bubb KJ; Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
  • Harmer JA; Kolling Institute of Medical Research, Cardiothoracic and Vascular Health, University of Sydney, St Leonards, New South Wales, Australia.
  • Finemore M; Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
  • Aitken SJ; Department of Cardiology, Royal North Shore Hospital, St Leonards, New South Wales, Australia.
  • Ali ZS; Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
  • Billot L; Kolling Institute of Medical Research, Cardiothoracic and Vascular Health, University of Sydney, St Leonards, New South Wales, Australia.
  • Chow C; Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
  • Golledge J; Concord Repatriation General Hospital, Concord, New South Wales, Australia.
  • Mister R; Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
  • Gray MP; Kolling Institute of Medical Research, Cardiothoracic and Vascular Health, University of Sydney, St Leonards, New South Wales, Australia.
  • Grieve SM; The George Institute for Global Health, UNSW Sydney, Newtown, New South Wales, Australia.
  • Hamburg N; Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
  • Keech AC; The George Institute for Global Health, UNSW Sydney, Newtown, New South Wales, Australia.
  • Patel S; Westmead Applied Research Centre, Faculty of Medicine and Health, University of Sydney, Westmead, New South Wales, Australia.
  • Puttaswamy V; Department of Cardiology, Westmead Hospital, Westmead, New South Wales, Australia.
  • Figtree GA; Vascular Biology Unit, James Cook University Queensland Research Centre for Peripheral Vascular Disease, Townsville, Queensland, Australia.
BMJ Open ; 11(9): e049858, 2021 09 28.
Article in En | MEDLINE | ID: mdl-34588252
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Adrenergic, beta-3 / Peripheral Arterial Disease Type of study: Clinical_trials Aspects: Ethics / Patient_preference Limits: Humans Language: En Journal: BMJ Open Year: 2021 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Adrenergic, beta-3 / Peripheral Arterial Disease Type of study: Clinical_trials Aspects: Ethics / Patient_preference Limits: Humans Language: En Journal: BMJ Open Year: 2021 Document type: Article Affiliation country: